Cognitive & Behavioral Assessment Automatic speech analysis for the assessment of patients with predementia and Alzheimer's disease

Evaluation of use of automatic speech analysis to assess the risk of mild cognitive impairment (MCI) and early Alzheimer's disease (AD)

While recording healthy elderly control (HC) subjects and patients with MCI or AD, several short cognitive voice tasks were performed. The audio recording is processed and the first audio marker is extracted using the audio signal processing technique. Next, test the sound marker to evaluate the ability to distinguish between HC, MCI, and AD. The second stage involves training an automatic classifier to detect MCI and AD using machine learning methods and detection detection accuracy.

Classification accuracy of automatic voice analysis is as follows: Classification accuracy between HC and MCI is 79% ± 5%; ratio between HC and AD patients is 87% ± 3%; between MCI and AD patients 80% ± 5%, proving the usefulness of the evaluation

Automatic voice analysis can be another objective evaluation tool for cognitive decline in the elderly

Mild cognitive impairment (MCI) is a premature baby syndrome known before the onset of Alzheimer's disease. Dahlgren and Gibas measured the patient's memory function using MCI and Montreal Cognitive Assessment (MoCA), a standard test for diagnosis of Alzheimer's disease. The MoCA score ranged from 0 to 30. A score of 26/30 or higher was considered normal. The average score for MCI patients was 22.1 / 30, and the average score for Alzheimer's disease patients was 16.2 / 30. The results of this study are from one patient but they certainly believe that a combination of ketone food, HIIT and memory game applications (such as PEAK) can help those who have experienced premature infant syndrome I will. We are looking for a safe and reliable method to prevent and treat mild cognitive impairment and Alzheimer's disease so we can expect further research on similar interventions in the coming years.

Alzheimer's disease is an acquired cognitive dysfunction and behavior disorder, unknown and may develop into dementia. Potential progressive memory loss is most common in Alzheimer's disease patients. Many treatments for Alzheimer's disease have been explored. The main Alzheimer's disease drugs are centrally acting cholinesterase inhibitors. Alzheimer's disease (AD) is a severe incurable dementia that can lead to language, language, memory, and impairment of basic athletic performance and cognitive impairment (Buckley, 2011). Currently in the United States, 5.2 million people live with AD (Alzheimer's Association, 2013).

Alzheimer's disease (AD) is associated. Alzheimer's disease (AD) is a disease of the brain that slowly eliminates memory, thinks about skills, and completes the ability to slowly pursue trivia. Alzheimer's disease is classified as cognitive loss - thought, memory, inference, and ability to interfere with people's daily lives and activities. (**** 1 *) Dementia may vary depending on the type of brain changes such as Lewy body disease (This is abnormal)

Alzheimer's disease (AD) is an irreversible neurodegenerative disease that gradually hinders cognitive and behavioral abilities. In individuals suffering from this disease, cognitive decline appears as memory impairment, reasoning, judgment, visual spatial ability, and language function. In behavior, unpredictable personality changes are more likely to occur. - Pick's Disease Pick's Disease is a type of dementia characterized by progress in social skills and irreversible deterioration and personality changes, as well as damage to intelligence, memory and language. In 1892, German neurologist, Arnold Pick, studied patients with dementia and aphasia. When the patient dies, his brain contracts and brain cells die in certain areas of the brain (atrophy).